Indefinite Delivery Contract 36C24423D0013
Award Date
11/4/22
Last Date to Order
11/3/27
Federal Agency
Veterans Integrated Service Network 4
Ultimate Awardee
Nuclear Diagnostic Products, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 awarded a single award indefinite delivery contract to Nuclear Diagnostic Products, Inc. to provide radiopharmaceuticals. Under the contract, three firm fixed price delivery orders were issued for a combined value of $1,142,529.63 to supply products to VA medical facilities in New Jersey, Pennsylvania and Delaware through March 2026. The original solicitation sought radiopharmaceuticals to...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business that is certified as an economically disadvantaged woman-owned small business. The contract has a total ceiling value of $3,129,016.00 and a period of performance from November 16, 2020 to November 15, 2025. It is a single-award IDC that allows for the ordering of various pharmaceutical products...
The key products and services being delivered under this federal contract IDV award are specialized pharmacy services and hazardous compounding for chemotherapy and other intravenous medications to support the Department of Veterans Affairs (VA) healthcare system. The prime contractor, Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy), a subsidiary of UnitedHealth Group Incorporated, has been awarded a single-award Indefinite Delivery Contract (IDC) worth $6.75 million by...
This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a small disadvantaged business. The $576,677.75 single-award IDC, with a performance period through September 2029, will provide the VA with a range of radiopharmaceutical products and services to support nuclear medicine operations at the VA Greater Los Angeles Healthcare...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded a single-award Indefinite Delivery Contract (IDC) to Pine Pharmaceuticals LLC, an FDA-registered 503B outsourcing facility, to provide 503B compounding pharmaceutical products and services. The $136,800 IDC has an ultimate completion date of September 30, 2025. Under this IDC, the VA VHA has issued two firm-fixed price delivery orders totaling $136,800. The first order, valued at $68,400, was awarded on...
The U.S. Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to Nuclear Diagnostic Products, Inc., a for-profit radiopharmaceutical supplier, to provide general radiopharmaceuticals to support nuclear medicine imaging procedures for the VA's Veterans Integrated Service Network (VISN) 2 healthcare system. The $4,038,178.15 IDC, which does not have a set-aside designation, has a period of performance through February 2026. Multiple firm fixed-price delivery orders...
The Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network 16 (VISN 16) has awarded an Indefinite Delivery Contract (IDC) to Numedrx Pharmacy Solutions LLC, a self-certified small disadvantaged business, to provide radiopharmaceutical supplies. This $2,692,693.25 single-award IDC, with a period of performance through September 2025, allows VISN 16 to issue firm fixed price delivery orders as needed to procure critical radiopharmaceutical products...
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The $2.29 million single-award IDC, with a period of performance through January 2030, is for the supply of radiopharmaceuticals, including specialized medical isotopes, diagnostic imaging agents, and therapeutic radioisotopes, to support nuclear medicine procedures, PET scans,...
This Indefinite Delivery Contract (IDC) was awarded by the Veterans Integrated Service Network 5 (VISN 5), a component of the U.S. Department of Veterans Affairs (VA), to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract has a ceiling value of $2,162,919.87 and a period of performance extending to March 31, 2030. The contract is for the provision of radiopharmaceuticals, which are critical for nuclear medicine diagnostic services at VA medical centers. RLS (USA)...
The U.S. Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, for the supply of nuclear medicine radiopharmaceuticals. The IDC, with a ceiling value of $1,500,000, has a performance period of April 27, 2023 to April 26, 2028. Under this IDC, the VA has issued several firm-fixed-price delivery orders to Jubilant Radiopharma for the...